Gene regulation in brain may explain repetitive behaviors in Rett syndrome patients
Janssen Biotech announced the FDA has approved STELARA® (ustekinumab) for treatment of moderately to severerely active Crohn’s disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis factor blocker. September 26, 2016